Navigation Links
Organovo Reports 2012 Financial Results
Date:3/18/2013

ring the development stage(50,245)(6,692)Total stockholders' deficit(5,303)(1,835)Total Liabilities and Stockholders' Deficit$16,749$1,409ORGANOVO HOLDINGS, INC. (A development stage company) CONSOLIDATED STATEMENTS OF OPERATIONS (in thousands except per share data) Year EndedDecember 31,2012Year EndedDecember 31,2011Period from

April 19, 2007(Inception) throughDecember 31, 2012RevenueProduct$—$224$224Collaborations1,0356881,798Grants16257826Total Revenue1,1979692,848Cost of product revenue—121134Selling, general, and administrative expenses7,0801,7339,747Research and development expenses3,4361,4206,634Loss from Operations(9,319)(2,305)(13,667)Other Income (Expense)Fair value of warrant liabilities in excess of proceeds received(19,019)—(19,019)Change in fair value of warrant liabilities(9,931)(7)(9,938)Financing transaction costs in excess of proceeds received(2,130)—(2,130)Loss on inducement to exercise warrants(1,904)—(1,904)Loss on disposal of fixed assets(158)—(158)Interest expense(1,088)(2,067)(3,406)Interest income5—7Other expense(9)(4)(30)Total Other Income (Expense)(34,234)(2,078)(36,578)Net Loss$(43,553)$(4,383)$(50,245)Net loss per common share - basic and diluted$(1.01)$(0.19)Weighted average number of shares used in computing net loss per share - basic and diluted43,149,65722,925,694ORGANOVO HOLDINGS, INC. (A development stage company) CONSOLIDATED STATEMENTS OF CASH FLOWS(in thousands)Year EndedDecember 31,2012Year EndedDecember 31,2011Period from

April 19, 2007(Inception) throughDecember 31, 2012Cash Flows From Operating ActivitiesNet loss$

(43,553)$

(4,383)$

(50,245)Adjustments to reconcile net loss to net cash used in operating activities:Amortization of debt discount8961,1882,084Loss on disposal of fixed assets158—158Depreciation and amortization19568351Amortization of deferred financing costs319119438Amortization of warrants issued for services55
'/>"/>

SOURCE Organovo Holdings, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Organovo Holdings, Inc. announces redemption of 2.9 million outstanding warrants
2. Organovo and OHSU Knight Cancer Institute Announce Collaboration in Cancer Research
3. Market Boosted by Strong Tech Earnings: Bank of America Corp., MAP Pharmaceuticals Inc., Swingplane Ventures Inc., World Moto, Inc., Organovo Holdings, Inc.
4. Organovo Reports Q2 2012 Financial Results, Provides Business Update
5. Organovo, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
6. Organovo Announces Two Issued Patents, First Company Patent and Key Founder Patent
7. Organovo Holdings Appoints James T. Glover to Board of Directors
8. China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2012
9. Orexigen Therapeutics Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2012
10. Isis Pharmaceuticals Reports Clinical Data Showing Blunting of Severe Increases in CRP Following Endotoxin Challenge With ISIS-CRP Rx
11. Addus HomeCare Reports Fourth Quarter 2012 Results Completes Sale of Home Health Assets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... Texas , Sept. 4, 2015  Luminex Corporation ... present at the Morgan Stanley Global Healthcare Conference to ... Grand Hyatt Hotel in New York City ... at 11:40 a.m. Eastern time on Friday, September 18, ... accessed at Luminex Corporation,s website at http://www.luminexcorp.com . ...
(Date:9/4/2015)... N.J. , Sept. 4, 2015  PTC ... to announce five recipients of its first-ever global ... Innovation, Vision and Empowerment), designed to aid nonprofit ... muscular dystrophy (DMD) community. The announcement is made ... international World Duchenne Awareness Day on Monday, September ...
(Date:9/4/2015)... 2015 Future Prospects for Companies ... Allergic Rhinitis drugs - new study showing you ... the market for allergic rhinitis drugs heading? What are ... new report shows you potential revenues and other trends ... Our 326 page report provides 273 tables, charts, and ...
Breaking Medicine Technology:Luminex Corporation To Present At The Morgan Stanley Global Healthcare Conference 2PTC Therapeutics Announces Five Winners In Its First-ever Global Duchenne Muscular Dystrophy Patient Group Award 2PTC Therapeutics Announces Five Winners In Its First-ever Global Duchenne Muscular Dystrophy Patient Group Award 3PTC Therapeutics Announces Five Winners In Its First-ever Global Duchenne Muscular Dystrophy Patient Group Award 4Allergic Rhinitis Drugs Market Forecast 2015-2025 2Allergic Rhinitis Drugs Market Forecast 2015-2025 3Allergic Rhinitis Drugs Market Forecast 2015-2025 4Allergic Rhinitis Drugs Market Forecast 2015-2025 5Allergic Rhinitis Drugs Market Forecast 2015-2025 6Allergic Rhinitis Drugs Market Forecast 2015-2025 7
... Pharmasset, Inc.,(Nasdaq: VRUS ), a clinical stage pharmaceutical ... viral,infections, reported financial results for the fiscal year ended September ... cash and cash,equivalents and short term investments. , ... Clevudine , ...
... PHILADELPHIA, December 11, Rosetta Genomics, Ltd. (NASDQ: ROSG), ... the,commercial availability of its first diagnostic test, miRview(TM) ... Genomics,CLIA-certified lab in Philadelphia. , ... may contact 1-888-522-7971, or visit the,company,s website ...
Cached Medicine Technology:Pharmasset Reports Fiscal Year End 2008 Financial Results 2Pharmasset Reports Fiscal Year End 2008 Financial Results 3Pharmasset Reports Fiscal Year End 2008 Financial Results 4Pharmasset Reports Fiscal Year End 2008 Financial Results 5Pharmasset Reports Fiscal Year End 2008 Financial Results 6Pharmasset Reports Fiscal Year End 2008 Financial Results 7Pharmasset Reports Fiscal Year End 2008 Financial Results 8Pharmasset Reports Fiscal Year End 2008 Financial Results 9Rosetta Genomics Announces Commercial Availability of its First MicroRNA-Based Diagnostic Test; Will Host Teleconference to Discuss Launch of Future Tests 2Rosetta Genomics Announces Commercial Availability of its First MicroRNA-Based Diagnostic Test; Will Host Teleconference to Discuss Launch of Future Tests 3Rosetta Genomics Announces Commercial Availability of its First MicroRNA-Based Diagnostic Test; Will Host Teleconference to Discuss Launch of Future Tests 4Rosetta Genomics Announces Commercial Availability of its First MicroRNA-Based Diagnostic Test; Will Host Teleconference to Discuss Launch of Future Tests 5
(Date:9/4/2015)... ... September 04, 2015 , ... On the ... effectively doubled the size of its annual health tech innovation program. Now featuring ... health startups to compete for cash and prizes to advance their technologies toward ...
(Date:9/4/2015)... ... September 04, 2015 , ... IVF New England, one of the largest ... "ManchVegas Happy Hour" in Manchester for women who wish to learn more about their ... Elm restaurant and lounge, 827 Elm Street, Manchester, NH from 6PM to 7PM , ...
(Date:9/4/2015)... , ... September 04, 2015 , ... ... three separate “Partner of the Year” awards at this year’s Microsoft Worldwide Partner ... Microsoft’s 2015 “Partner of the Year” Award Winner for Data Platform services, the ...
(Date:9/4/2015)... Pittsburgh, PA (PRWEB) , ... September 04, 2015 , ... Many consumers are looking for ... Cups could be their solution. , The patent-pending K Med Cups provide a quick and ... they help to relieve a cold, flu or cough. As a result, they enhance comfort ...
(Date:9/4/2015)... Washington (PRWEB) , ... September 04, 2015 , ... ... design and development of its first neighborhood created specifically for adults with intellectual, ... in the Phoenix Metro area and feature 30 cottage or “pocket” homes. In ...
Breaking Medicine News(10 mins):Health News:Insight Product Development Startup Competition on Track to Double Program Impact 2Health News:Insight Product Development Startup Competition on Track to Double Program Impact 3Health News:IVF New England to Host ManchVegas New Hampshire Fertility Happy Hour on October 15, 2015 in Manchester for Women Who Wish to Learn More About Fertility and Egg Freezing 2Health News:Scalability Experts is Awarded Three Separate 2015 “Partner of the Year” Awards at Microsoft’s Worldwide Partner Conference 2Health News:Scalability Experts is Awarded Three Separate 2015 “Partner of the Year” Awards at Microsoft’s Worldwide Partner Conference 3Health News:Scalability Experts is Awarded Three Separate 2015 “Partner of the Year” Awards at Microsoft’s Worldwide Partner Conference 4Health News:Redesigned Packaging for Powdered Medicinal Mix Invented by InventHelp® Client (CBA-2637) 2Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 2Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 3Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 4
... Labor Law Reform , , CHICO, ... reached a tentative agreement with hospital management for a new contract ... and an average wage increase of 33 percent over four years. ... would cap more than a year of bargaining that followed a ...
... MINNEAPOLIS, Dec. 3 Upsher-Smith Laboratories, Inc.,announced its plans ... prenatal vitamin with the most plant-based Docosahexaenoic acid (DHA,265 ... mothers who,are breastfeeding.(1-6) , ... from a natural,plant source grown outside the ocean.(1,7) ...
... healthy immune response , , WEDNESDAY, Dec. 3 (HealthDay News) ... risk of asthma, according to Swiss researchers, who conducted ... infants. , By the time they were 8 years ... diagnosed with asthma for which they,d been prescribed inhaled ...
... Two cities in Tennessee have adopted,New Jersey,s unique and successful ... article in the Chattanooga Times Free Press on Monday,reported that ... after,their mayors learned of the New Jersey program through their ... ) , The Mayors ...
... has found that a school-based asthma education program conducted in ... and increase the number of days that children who suffered ... will be published this month in the Journal of ... have asthma in the U.S., according to the Centers for ...
... - Methods used by the body to selectively suppress ... and more effective, according to scientists. , "If you ... every tissue transplant much more like a fetus," said ... of Georgia Immunotherapy Center and Georgia Research Alliance Eminent ...
Cached Medicine News:Health News:Healthcare Workers Reach Tentative Agreement With Enloe Medical Center 2Health News:First and Only Single Capsule Daily Rx Prenatal Vitamin With Plant-Based DHA Now Available 2Health News:First and Only Single Capsule Daily Rx Prenatal Vitamin With Plant-Based DHA Now Available 3Health News:First and Only Single Capsule Daily Rx Prenatal Vitamin With Plant-Based DHA Now Available 4Health News:C-Section Might Boost Baby's Asthma Risk 2Health News:New Jersey's 'Mayors Wellness Campaign' Goes National! 2Health News:Study shows school-based program enables children and adolescents to better manage chronic disease 2Health News:New approaches to protecting transplanted organs make first steps toward patients 2Health News:New approaches to protecting transplanted organs make first steps toward patients 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: